STUDYOPS and OPTIMUS MEDICAL AWARDED 2 HIV TRIALS

By |2014-11-25T18:54:18+00:00November 25th, 2014|Pharma News|

Studyops and Optimus, San Francisco, CA. were awarded 2  Studies for patients with HIV. Screening will begin in January. Check out www.studyops.com for our contact information to answer any questions. Please welcome Optimus, Dr. Shawn Hassler and his team to the Studyops family.

Comments Off on STUDYOPS and OPTIMUS MEDICAL AWARDED 2 HIV TRIALS

World Drug Bill Will Reach $1.3 Trillion By 2018

By |2017-04-25T18:03:54+00:00November 20th, 2014|Pharma News|

The world spends most of its money on medicine. New study reveals that by the year 2018 the world drug bill will reach approximately $1.3 trillion. The new treatments for cancer and hepatitis C contribute to the rise. Another factor for this increase are the people that buy pharmaceuticals using their rising incomes. The new [...]

Comments Off on World Drug Bill Will Reach $1.3 Trillion By 2018

Payers’ hep C delay tactics work: Coverage hurdles may be dampening Harvoni script growth

By |2017-04-25T18:03:54+00:00November 19th, 2014|Pharma News|

Gilead's ($GILD) hep C wonder combo, Harvoni, boasts cure rates as high as 99.1%, and analysts have said they expect it to rack up $10 billion a year in sales, becoming the fastest-growing drug of all time on the way there. But if all of that's the case, then why are U.S. scripts lagging [...]

Comments Off on Payers’ hep C delay tactics work: Coverage hurdles may be dampening Harvoni script growth
Go to Top